Home › Funds › Eversept Partners, LP › GPCR
Eversept Partners, LP position in GPCR
STRUCTURE THERAPEUTICS INC · Health Care
Eversept Partners, LP reported holding 196,302 shares of GPCR (STRUCTURE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$10.5M, representing 0.55% of its reported portfolio and ranking #46 among its reported holdings. Eversept Partners, LP has disclosed GPCR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's GPCR position evolved
Eversept Partners, LP first disclosed a stake in GPCR in Q2 2025 at 99,338 shares (US$2.1M). The position peaked in Q2 2026 at 196,302 shares, worth US$10.5M. Across 5 filings, Eversept Partners, LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 196,302 shares valued at US$10.5M — an increase of 58,266 shares quarter over quarter.. Notable position changes include a 67% increase in Q3 2025 (shares rose 148% over the following quarter), a 42% increase in Q2 2026 (shares fell 42% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 99.34K | $2.06M | New |
| Q3 2025 | 166.39K | $4.66M | Add |
| Q4 2025 | 127.56K | $8.87M | Reduce |
| Q1 2026 | 138.04K | $6.65M | Add |
| Q2 2026 | 196.30K | $10.54M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GPCR and 13F data
GPCR (STRUCTURE THERAPEUTICS INC) is a Health Care company. 33 other funds we track also report a position in GPCR — the largest reported positions include Avoro Capital Advisors LLC (US$351.8M), Deep Track Capital, LP (US$254.4M), BVF INC/IL (US$180.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GPCR
- Avoro Capital Advisors LLC 6.56M sh · $351.84M · Q2 2026
- Deep Track Capital, LP 4.74M sh · $254.40M · Q2 2026
- BVF INC/IL 3.37M sh · $180.70M · Q2 2026
- ORBIMED ADVISORS LLC 2.21M sh · $118.58M · Q2 2026
- RTW INVESTMENTS, LP 1.61M sh · $86.27M · Q2 2026
- BAKER BROS. ADVISORS LP 1.43M sh · $76.88M · Q2 2026
- Casdin Capital 1.18M sh · $63.06M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 1.09M sh · $58.29M · Q2 2026
- Siren, L.L.C. 872.97K sh · $46.85M · Q2 2026
- PACIFIC HEIGHTS ASSET MANAGEMENT LLC 800.00K sh · $42.94M · Q2 2026
- Rock Springs Capital Management LP 640.32K sh · $34.37M · Q2 2026
- Logos Global Management LP 500.00K sh · $26.84M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held GPCR?
Eversept Partners, LP has disclosed GPCR holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Eversept Partners, LP's current position in GPCR?
As of Q2 2026, Eversept Partners, LP holds 196.30K shares of GPCR (STRUCTURE THERAPEUTICS INC), valued at $10.54M, representing 0.55% of its reported portfolio and ranking #46.
Has Eversept Partners, LP been buying or selling GPCR?
In the latest 13F filing (Q2 2026), Eversept Partners, LP increased its position in GPCR. The position peaked in Q2 2026 at 196.30K shares.
Which other funds hold GPCR?
Other major institutional holders of GPCR include Avoro Capital Advisors LLC, Deep Track Capital, LP, BVF INC/IL, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.